LMHWH ELISA Kits
Low Molecular Weight Heparin (LMWH) is a class of anticoagulant medications widely used in the prevention and treatment of thromboembolic disorders. Accurate quantification of LMWH levels in biological samples is essential for therapeutic monitoring, pharmacokinetic studies, and research applications.
Key Features:
- Specificity: Utilize antibodies that selectively bind to LMWH, minimizing cross-reactivity with other heparin forms or plasma components.
- Sensitivity: Capable of detecting low concentrations of LMWH, with detection limits often in the nanogram per milliliter (ng/mL) range.
- Sample Compatibility: Validated for use with various sample types, facilitating broad applicability in clinical and research settings.
Applications:
- Therapeutic Drug Monitoring: Assessing LMWH levels in patients to ensure therapeutic efficacy and minimize the risk of bleeding complications.
- Pharmacokinetic Studies: Evaluating the absorption, distribution, metabolism, and excretion of LMWH formulations.
- Research: Investigating the role of LMWH in various biological processes and its effects on coagulation pathways.
Examples of LMWH ELISA Kits:
- Human Low Molecular Weight Heparin (LMWH) ELISA Kit: A sandwich ELISA assay for measuring human LMWH in serum, plasma, and cell culture supernatants, with a detection range of 3.7–120 ng/mL and a sensitivity of less than 3.7 ng/mL. Abcam
- Low Molecular Weight Heparin (LMWH) ELISA Kit for Plasma: Designed for the quantitative measurement of LMWH levels in plasma or high-protein samples, suitable for pharmacokinetic and clinical research applications. Lifespan Tech
These LMWH ELISA kits are indispensable tools for clinicians and researchers aiming to monitor LMWH therapy, conduct pharmacokinetic analyses, and explore the anticoagulant's role in various physiological and pathological contexts.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|